During Q & A they were still expecting partnering for a Ph3 if I understood that correctly. Whether the sp at 2c or 20c, any deals will be negotiated based on trial data and the likelihood of a commercial outcome. Management is confident, market has written it off. Huge volume but in the end the shares got bought by someone who might agree with management. Time will tell who got it right today.
I went down today by holding 100k shares, can cope with that and will try to trade to compensate the losses over time for the next readout in about 12 months.
GLTA
Ann: ACW XanaCIDD phase 2a trial topline results, page-72
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $76.57M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.6¢ | $36.24K | 1.368M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 2786394 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 1074406 | 4 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| ACW (ASX) Chart |